Products in the Pipeline

Our pipeline consists of potentially first in class products with unique benefits to serve patient needs.

Cevira® - for the treatment of HPV and precancerous lesions of the cervix. Ready to enter into the Phase 3 clinical program.

Visonac® - for the treatment of inflammatory acne. Ready to enter into the Phase 3 clinical program.

Both Cevira® and Visonac® are open for partners specialized within dermatology (acne) and women's health.